INT206698

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.09
First Reported 2007
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 4
Total Number 4
Disease Relevance 3.06
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (HBS1L) translation (HBS1L) GTPase activity (HBS1L)
Anatomy Link Frequency
body 1
HBS1L (Homo sapiens)
Pain Link Frequency Relevance Heat
Codeine 1 38.24 Quite Low
cytokine 40 5.00 Very Low Very Low Very Low
headache 5 5.00 Very Low Very Low Very Low
Inflammation 4 5.00 Very Low Very Low Very Low
agonist 4 5.00 Very Low Very Low Very Low
alcohol 3 5.00 Very Low Very Low Very Low
Pain 2 5.00 Very Low Very Low Very Low
pruritus 2 5.00 Very Low Very Low Very Low
tolerance 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Hepatotoxicity 43 99.76 Very High Very High Very High
Acquired Immune Deficiency Syndrome Or Hiv Infection 52 98.92 Very High Very High Very High
Obesity 9 98.44 Very High Very High Very High
Malaria 58 97.16 Very High Very High Very High
Hepatitis C Virus Infection 11 97.00 Very High Very High Very High
Hepatotoxicity- Drug-induced 29 88.84 High High
Disease 7 85.84 High High
Mycobacterial Infection 48 78.56 Quite High
Jaundice 2 76.16 Quite High
Immunization 34 68.88 Quite High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
We provide evidence of a significant change in allele frequency in the HbS locus that could be observed within 2-3 generation in the presence of malaria transmission.
Regulation (change) of HbS associated with malaria
1) Confidence 0.09 Published 2010 Journal BMC Med Genet Section Body Doc Link PMC2829010 Disease Relevance 0.83 Pain Relevance 0
10 mIU/mL) were compared in the combined IMP321 groups and in the Engerix-B® group versus the control HBsAg alone group.


Regulation (control) of HBsAg
2) Confidence 0.03 Published 2007 Journal J Immune Based Ther Vaccines Section Body Doc Link PMC1852106 Disease Relevance 0.05 Pain Relevance 0
Addition of IMP321 to HBsAg resulted in earlier appearance of anti-HBs antibodies compared to the control HBsAg alone group.
Regulation (control) of HBsAg
3) Confidence 0.03 Published 2007 Journal J Immune Based Ther Vaccines Section Body Doc Link PMC1852106 Disease Relevance 0.37 Pain Relevance 0
The effect of confounders such as age, sex, HBsAg, concomitant drug intake, HIV status, body mass index, CD4 count and anti-HCV antibody was controlled.
Regulation (effect) of HBsAg in body associated with obesity, acquired immune deficiency syndrome or hiv infection and hepatitis c virus infection
4) Confidence 0.01 Published 2008 Journal PLoS ONE Section Body Doc Link PMC2265547 Disease Relevance 1.81 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox